Single-use technologies are playing a key role in scaling up cell and gene therapy manufacturing by reducing cleaning requirements, enabling rapid changeovers and supporting flexible, multi-product facilities.

The article explores how automation, standardisation and close collaboration with suppliers are helping the industry move towards robust commercial production. Wayne Bowen (TTP) discusses how combining single-use consumables with modular, automated platforms can deliver faster, more flexible and lower-risk manufacturing through closed, automated processes.

Read the article here.